Ask AI

Tuning in to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs

For advanced practice providers, gain in-depth knowledge on the role TYK2 plays in the pathophysiology of psoriasis and strategies for integrating TYK2-targeted, oral therapy in personalized treatment plans for patients with moderate to severe disease, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

  • Live Event
    Tuning In to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

TYK2 inhibition in psoriasis
The Evolving Psoriasis Treatment Landscape—From Injectable Biologics to Novel, Oral Small Molecules Targeting TYK2
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2025

Expires: October 22, 2026

Activities

Oral TYK2 psoriasis treatment
Tuning In to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 16, 2025

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners)

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb